Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIthaca Energy Regulatory News (ITH)

Share Price Information for Ithaca Energy (ITH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.60
Bid: 122.20
Ask: 123.00
Change: 0.80 (0.66%)
Spread: 0.80 (0.655%)
Open: 121.80
High: 122.60
Low: 121.00
Prev. Close: 121.80
ITH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

9 Nov 2022 07:07

RNS Number : 7536F
Goldman Sachs International
09 November 2022
 

09 November 2022

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Ithaca Energy plc

Stabilisation Notice

Goldman Sachs International (contact: Mark Maislish; telephone: +44 (0)20 7774 1000) hereby gives notice that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council.

The Securities:

Issuer:

Ithaca Energy plc

Shares:

Ordinary Shares of the Issuer (ISIN No. GB00BPJHV584)

Offering Size:

105,000,000 Ordinary Shares (excluding the over-allotment option)

Offer Price:

250 pence per share

Stabilisation:

Stabilisation Manager(s):

Goldman Sachs International

Plumtree Court, 25 Shoe Lane, London, EC4A 4AU, United Kingdom

 

Stabilisation period expected to start on:

09 November 2022

Stabilisation Period expected to end no later than:

08 December 2022

Trading venue where stabilisation may be undertaken:

London Stock Exchange, BATS, Chi-X

Greenshoe Option:

Terms:

Ithaca Energy plc has granted Goldman Sachs International, in its capacity as stabilisation manager and for the account of the underwriters, the option to acquire additional Shares at 250 pence per share

Maximum size of over-allotment facility:

15,000,000 Ordinary Shares

Duration:

This option may be executed at any time from 09 November to 08 December 2022

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at

a level higher than that which might otherwise prevail. However, there is no assurance that the

Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun,

may be ended at any time.

 

This announcement is for information only and does not constitute an offer or invitation to

underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice

in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the

United States, Australia, Canada, Japan or South Africa. Any failure to comply with these

restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement and the information contained herein, is not an offer of securities for sale in,

and is not for transmission to or publication, distribution or release, directly or indirectly, in the

United States of America (including its territories and possessions, any state of the United States

of America and the District of Columbia) (the "United States"). The securities being offered have

not been and will not be registered under the US Securities Act of 1933, as amended (the

"Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the

United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly,

in the United States unless registered under the Securities Act or pursuant to an exemption from,

or in a transaction not subject to, such registration requirements and in accordance with any

applicable securities laws of any state or other jurisdiction of the United States. No public offering

of the securities discussed herein is being made in the United States.

 

This announcement is directed only at: (A) persons in member states of the European Economic

Area (the "EEA") who are "qualified investors" within the meaning of Article 2(1)(e) of the EU

Prospectus Directive (Directive 2003/71/EC (and amendments thereto, including Directive

2010/73/EU, to the extent implemented in the relevant member state of the EEA) and includes

any relevant implementing measure in each relevant member state of the EEA) (the "Qualified

Investors"); (B) in the United Kingdom, Qualified Investors who are persons who (i) have

professional experience in matters relating to investments and who fall within the definition of

"investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000

(Financial Promotion) Order 2005 (as amended) (the "Order"); or (ii) are high net worth entities

falling within Article 49 of the Order; or (iii) are persons to whom it may otherwise be lawfully

communicated (all such persons together being referred to as "Relevant Persons"). If you are not

a Relevant Person, you will not be eligible to participate in the offering, and you should not act

upon, or rely on, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAFFPELNAFAA
Date   Source Headline
7th Jun 20247:00 amRNSDirector/PDMR Shareholding
6th Jun 20242:59 pmRNSDirector/PDMR Shareholding
29th May 20248:14 amRNSNotice of AGM
28th May 20247:01 amRNSFirst Quarter Results
28th May 20247:00 amRNSBoard of Directors & Executive Management Changes
16th May 20244:11 pmRNSSenior Independent Director Appointment
9th May 20249:33 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSCredit Rating Upgrade Reviews
1st May 20244:20 pmRNSDirector/PDMR Shareholding
23rd Apr 20245:33 pmRNSTransformational combination with ENI UK
17th Apr 20247:00 amRNSPDMR and PCA Notification
10th Apr 20249:59 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSThird Interim Dividend
2nd Apr 20247:00 amRNSDirectorate Change
27th Mar 20247:00 amRNSFull Year 2023 Results
27th Mar 20247:00 amRNSExclusivity Agreement with Eni S.p.A's UK Business
21st Mar 20247:00 amRNSAnnouncement of Interim Dividend
6th Mar 20242:17 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSFY 2023 Trading Update
7th Feb 202410:16 amRNSDirector/PDMR Shareholding
11th Jan 20242:11 pmRNSDirectors'/PDMR Shareholdings
5th Jan 20247:00 amRNSChief Executive Officer Change
7th Dec 20239:40 amRNSDirector/PDMR Shareholding
4th Dec 20232:22 pmRNSDirector/PDMR Shareholding
30th Nov 202310:37 amRNSSuccessful Completion of Remaining Stake in Cambo
23rd Nov 20231:49 pmRNSChange of Registered Office
22nd Nov 20237:00 amRNSQ3 2023 Financial Results
10th Nov 20231:22 pmRNSDirectors’/PDMR Shareholdings
1st Nov 20239:00 amRNSCompletion of acquisition remaining stake in Fotla
19th Oct 202312:14 pmRNSAdmission of Shares
10th Oct 202310:26 amRNSDirectors’/PDMR Shareholdings
4th Oct 202312:01 pmRNSIssue of Shares to the Employee Benefit Trust
3rd Oct 20234:40 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSIthaca Energy Development of the Rosebank Field
12th Sep 20237:00 amRNSIthaca to acquire remaining interest in Cambo
8th Sep 20239:59 amRNSDirectors’/PDMR Shareholdings
8th Sep 20237:00 amRNSSecond interim dividend for 2023
23rd Aug 20237:00 amRNSFirst Half Results for Six Months to 30 June 2023
23rd Aug 20237:00 amRNSAnnouncement of Interim Dividend
8th Aug 20234:57 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNSK2 Successful Exploration Well Results
12th Jul 20237:00 amRNSAcquisition of Fotla & three exploration licenses
7th Jul 20233:27 pmRNSDirectors’/PDMR Shareholdings
7th Jul 20233:00 pmRNSNon-Executive Director - Directorship update
21st Jun 20235:54 pmRNSDirector Dealings and Shareholdings
20th Jun 202310:15 amRNSChange of Registered Office
7th Jun 20238:10 amRNSDirectors’/PDMR Shareholdings
31st May 20237:00 amRNSFirst Quarter Results
26th May 20239:01 amRNSAmended PDMR and PCA Notification
24th May 20234:51 pmRNSResults of Annual General Meeting 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.